 | • レポートコード：20QY06-01676 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、グルカゴン様ペプチド-2（GLP-2）アゴニストのグローバル市場について種類別（ガテックス、レベスティブ）、用途別（病院、薬局、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・グルカゴン様ペプチド-2（GLP-2）アゴニスト市場の概要 ・世界の主要地域別グルカゴン様ペプチド-2（GLP-2）アゴニスト市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のグルカゴン様ペプチド-2（GLP-2）アゴニスト市場規模2015-2026：種類別（ガテックス、レベスティブ） ・世界のグルカゴン様ペプチド-2（GLP-2）アゴニスト市場規模2015-2026：用途別（病院、薬局、その他） ・グルカゴン様ペプチド-2（GLP-2）アゴニストの北米市場規模2015-2020 ・グルカゴン様ペプチド-2（GLP-2）アゴニストのヨーロッパ市場規模2015-2020 ・グルカゴン様ペプチド-2（GLP-2）アゴニストの中国市場規模2015-2020 ・グルカゴン様ペプチド-2（GLP-2）アゴニストの日本市場規模2015-2020 ・グルカゴン様ペプチド-2（GLP-2）アゴニストの東南アジア市場規模2015-2020 ・グルカゴン様ペプチド-2（GLP-2）アゴニストのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Takeda Pharmaceuticals） ・グルカゴン様ペプチド-2（GLP-2）アゴニストの製造コスト分析 ・販売チャネル、流通業者、顧客 ・グルカゴン様ペプチド-2（GLP-2）アゴニストの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Glucagon-like Peptide-2 (GLP-2) Agonist market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Teduglutide (brand names Gattex in the US and Revestive in Europe) is a 33-membered polypeptide and glucagon-like peptide-2 (GLP-2) analog that is used for the treatment of short bowel syndrome.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Glucagon-like Peptide-2 (GLP-2) Agonist market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Glucagon-like Peptide-2 (GLP-2) Agonist industry.
Based on our recent survey, we have several different scenarios about the Glucagon-like Peptide-2 (GLP-2) Agonist YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Glucagon-like Peptide-2 (GLP-2) Agonist will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Glucagon-like Peptide-2 (GLP-2) Agonist market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Glucagon-like Peptide-2 (GLP-2) Agonist market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Glucagon-like Peptide-2 (GLP-2) Agonist market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Glucagon-like Peptide-2 (GLP-2) Agonist market. The report also includes nautical information, where it shows Glucagon-like Peptide-2 (GLP-2) Agonist market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Glucagon-like Peptide-2 (GLP-2) Agonist market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Glucagon-like Peptide-2 (GLP-2) Agonist market.
Geographical Analysis:
Based on region, the global Glucagon-like Peptide-2 (GLP-2) Agonist market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Glucagon-like Peptide-2 (GLP-2) Agonist market are
Takeda Pharmaceuticals
…
Segment by Type
Gattex
Revestive
Segment by Application
Hospital
Pharmacy
Other
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Glucagon-like Peptide-2 (GLP-2) Agonist market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Glucagon-like Peptide-2 (GLP-2) Agonist market.
• The market share of the global Glucagon-like Peptide-2 (GLP-2) Agonist market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Glucagon-like Peptide-2 (GLP-2) Agonist market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Glucagon-like Peptide-2 (GLP-2) Agonist market.
1 Glucagon-like Peptide-2 (GLP-2) Agonist Market Overview
1.1 Glucagon-like Peptide-2 (GLP-2) Agonist Product Scope
1.2 Glucagon-like Peptide-2 (GLP-2) Agonist Segment by Type
1.2.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Type (2020-2026)
1.2.2 Gattex
1.2.3 Revestive
1.3 Glucagon-like Peptide-2 (GLP-2) Agonist Segment by Application
1.3.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Glucagon-like Peptide-2 (GLP-2) Agonist Market Estimates and Forecasts (2015-2026)
1.4.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Growth Rate (2015-2026)
1.4.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue and Growth Rate (2015-2026)
1.4.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Glucagon-like Peptide-2 (GLP-2) Agonist Industry Impact
1.5.1 How the Covid-19 is Affecting the Glucagon-like Peptide-2 (GLP-2) Agonist Industry
1.5.1.1 Glucagon-like Peptide-2 (GLP-2) Agonist Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Glucagon-like Peptide-2 (GLP-2) Agonist Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Glucagon-like Peptide-2 (GLP-2) Agonist Players to Combat Covid-19 Impact
2 Glucagon-like Peptide-2 (GLP-2) Agonist Estimate and Forecast by Region
2.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Region (2015-2020)
2.2.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Region (2015-2020)
2.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Glucagon-like Peptide-2 (GLP-2) Agonist Estimates and Projections (2015-2026)
2.4.2 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Estimates and Projections (2015-2026)
2.4.3 China Glucagon-like Peptide-2 (GLP-2) Agonist Estimates and Projections (2015-2026)
2.4.4 Japan Glucagon-like Peptide-2 (GLP-2) Agonist Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Estimates and Projections (2015-2026)
2.4.6 India Glucagon-like Peptide-2 (GLP-2) Agonist Estimates and Projections (2015-2026)
3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Competition Landscape by Players
3.1 Global Top Glucagon-like Peptide-2 (GLP-2) Agonist Players by Sales (2015-2020)
3.2 Global Top Glucagon-like Peptide-2 (GLP-2) Agonist Players by Revenue (2015-2020)
3.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucagon-like Peptide-2 (GLP-2) Agonist as of 2019)
3.4 Global Glucagon-like Peptide-2 (GLP-2) Agonist Average Price by Company (2015-2020)
3.5 Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Glucagon-like Peptide-2 (GLP-2) Agonist Players (Opinion Leaders)
4 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size by Type
4.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Historic Market Review by Type (2015-2020)
4.1.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type (2015-2020)
4.1.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Type (2015-2020)
4.1.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Price by Type (2014-2020)
4.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Type (2021-2026)
4.2.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Forecast by Type (2021-2026)
4.2.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Price Forecast by Type (2021-2026)
5 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size by Application
5.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Historic Market Review by Application (2015-2020)
5.1.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application (2015-2020)
5.1.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Application (2015-2020)
5.1.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Price by Application (2015-2020)
5.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Application (2021-2026)
5.2.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Forecast by Application (2021-2026)
5.2.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Price Forecast by Application (2021-2026)
3 North America Glucagon-like Peptide-2 (GLP-2) Agonist Market Facts & Figures
3.2 North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Company (2015-2020)
3.3 North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type (2015-2020)
3.4 North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application (2015-2020)
4 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Market Facts & Figures
4.2 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Company (2015-2020)
4.3 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type (2015-2020)
4.4 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application (2015-2020)
5 China Glucagon-like Peptide-2 (GLP-2) Agonist Market Facts & Figures
5.2 China Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Company (2015-2020)
5.3 China Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type (2015-2020)
5.4 China Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application (2015-2020)
6 Japan Glucagon-like Peptide-2 (GLP-2) Agonist Market Facts & Figures
6.2 Japan Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Company (2015-2020)
6.3 Japan Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type (2015-2020)
6.4 Japan Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application (2015-2020)
7 Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Market Facts & Figures
7.2 Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application (2015-2020)
8 India Glucagon-like Peptide-2 (GLP-2) Agonist Market Facts & Figures
8.2 India Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Company (2015-2020)
8.3 India Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type (2015-2020)
8.4 India Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Glucagon-like Peptide-2 (GLP-2) Agonist Business
12.1 Takeda Pharmaceuticals
12.1.1 Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Corporation Information
12.1.2 Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Business Overview and Total Revenue
12.1.3 Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Products Offered
12.1.5 Takeda Pharmaceuticals Recent Development
…
13 Glucagon-like Peptide-2 (GLP-2) Agonist Manufacturing Cost Analysis
13.1 Glucagon-like Peptide-2 (GLP-2) Agonist Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Glucagon-like Peptide-2 (GLP-2) Agonist
13.4 Glucagon-like Peptide-2 (GLP-2) Agonist Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Glucagon-like Peptide-2 (GLP-2) Agonist Distributors List
14.3 Glucagon-like Peptide-2 (GLP-2) Agonist Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Glucagon-like Peptide-2 (GLP-2) Agonist Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Glucagon-like Peptide-2 (GLP-2) Agonist Players to Combat Covid-19 Impact
Table 8. Global Market Glucagon-like Peptide-2 (GLP-2) Agonist Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units) by Region (2015-2020)
Table 10. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Region (2015-2020)
Table 11. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Share by Region (2015-2020)
Table 13. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Share Forecast by Region (2021-2026)
Table 17. Global Glucagon-like Peptide-2 (GLP-2) Agonist (K Units) of Key Companies (2015-2020)
Table 18. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Share by Company (2015-2020)
Table 19. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Share by Company (2015-2020)
Table 21. Global Glucagon-like Peptide-2 (GLP-2) Agonist by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucagon-like Peptide-2 (GLP-2) Agonist as of 2019)
Table 22. Global Glucagon-like Peptide-2 (GLP-2) Agonist Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Manufacturing Sites and Area Served
Table 24. Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Glucagon-like Peptide-2 (GLP-2) Agonist Players
Table 27. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units) by Type (2015-2020)
Table 28. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Share by Type (2015-2020)
Table 29. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Glucagon-like Peptide-2 (GLP-2) Agonist Price (K Units) by Type (2015-2020)
Table 31. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Share by Type (2021-2026)
Table 32. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Share by Type (2021-2026)
Table 34. Global Glucagon-like Peptide-2 (GLP-2) Agonist Price (K Units) by Type (2021-2026)
Table 35. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units) by Application (2015-2020)
Table 36. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Share by Application (2015-2020)
Table 37. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Glucagon-like Peptide-2 (GLP-2) Agonist Price (K Units) by Application (2015-2020)
Table 39. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units) by Application (2021-2026)
Table 40. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Share by Application (2021-2026)
Table 41. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Share by Application (2021-2026)
Table 43. Global Glucagon-like Peptide-2 (GLP-2) Agonist Price (K Units) by Application (2021-2026)
Table 44. United States Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units) by Company (2015-2020)
Table 45. United States Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Company (2015-2020)
Table 46. United States Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units) by Type (2015-2020)
Table 47. United States Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type (2015-2020)
Table 48. United States Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units) by Application (2015-2020)
Table 49. United States Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application (2015-2020)
Table 50. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units) by Company (2015-2020)
Table 51. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Company (2015-2020)
Table 52. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units) by Type (2015-2020)
Table 53. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type (2015-2020)
Table 54. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units) by Application (2015-2020)
Table 55. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type (2015-2020)
Table 56. China Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units) by Company (2015-2020)
Table 57. China Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Company (2015-2020)
Table 58. China Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units) by Type (2015-2020)
Table 59. China Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type (2015-2020)
Table 60. China Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units) by Application (2015-2020)
Table 61. China Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application (2015-2020)
Table 62. Japan Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units) by Company (2015-2020)
Table 63. Japan Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Company (2015-2020)
Table 64. Japan Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units) by Type (2015-2020)
Table 65. Japan Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type (2015-2020)
Table 66. Japan Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units) by Application (2015-2020)
Table 67. Japan Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application (2015-2020)
Table 74. India Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units) by Company (2015-2020)
Table 75. India Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Company (2015-2020)
Table 76. India Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units) by Type (2015-2020)
Table 77. India Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type (2015-2020)
Table 78. India Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units) by Application (2015-2020)
Table 79. India Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application (2015-2020)
Table . Takeda Pharmaceuticals Corporation Information
Table . Takeda Pharmaceuticals Description and Business Overview
Table . Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Product
Table . Takeda Pharmaceuticals Recent Development
Table 85. Production Base and Market Concentration Rate of Raw Material
Table 86. Key Suppliers of Raw Materials
Table 87. Glucagon-like Peptide-2 (GLP-2) Agonist Distributors List
Table 88. Glucagon-like Peptide-2 (GLP-2) Agonist Customers List
Table 89. Market Key Trends
Table 90. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 91. Key Challenges
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Glucagon-like Peptide-2 (GLP-2) Agonist Product Picture
Figure 2. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Pharmacy Examples
Figure 8. Other Examples
Figure 9. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Glucagon-like Peptide-2 (GLP-2) Agonist Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Glucagon-like Peptide-2 (GLP-2) Agonist Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Glucagon-like Peptide-2 (GLP-2) Agonist Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Glucagon-like Peptide-2 (GLP-2) Agonist Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Glucagon-like Peptide-2 (GLP-2) Agonist Players Market Share by Revenue in Glucagon-like Peptide-2 (GLP-2) Agonist 2015 & 2019
Figure 27. Glucagon-like Peptide-2 (GLP-2) Agonist Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Share by Type (2015-2020)
Figure 29. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Share by Application (2015-2020)
Figure 31. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type in 2019
Figure 33. United States Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type in 2019
Figure 34. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Company in 2019
Figure 35. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type in 2019
Figure 36. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application in 2019
Figure 37. China Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Company in 2019
Figure 38. China Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type in 2019
Figure 39. China Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application in 2019
Figure 40. Japan Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Company in 2019
Figure 41. Japan Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type in 2019
Figure 42. Japan Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application in 2019
Figure 43. Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Company in 2019
Figure 44. Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type in 2019
Figure 45. Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application in 2019
Figure 46. India Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Company in 2019
Figure 47. India Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type in 2019
Figure 48. India Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application in 2019
Figure 49. Takeda Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Glucagon-like Peptide-2 (GLP-2) Agonist
Figure 52. Manufacturing Process Analysis of Glucagon-like Peptide-2 (GLP-2) Agonist
Figure 53. Glucagon-like Peptide-2 (GLP-2) Agonist Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
グルカゴンの世界市場レポート2020 Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control syst…- ゴナドトロピン放出ホルモン作用物質の世界市場レポート2020 A recently published report by QY Research titled Global Gonadotropin-releasing Hormone Agonist Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistical…
- ゴナドトロピン放出ホルモン作用物質薬の世界市場レポート2020 A recently published report by QY Research titled Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also stati…
- オピオイド作動薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Opioids Agonist Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.3% in the forecast period of 2020 to 2025 and will expected to reach USD 18590 million by 2025, from USD 16980 million in 2019. The Opioids Agonist …
- ペプチド核酸の世界市場レポート2020 Market Analysis and Insights: Global Peptide Nucleic Acid Market The global Peptide Nucleic Acid market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Peptide Nucleic Acid Scope and Market Size The global Pepti…